Navigation Links
Zacks Sell List Highlights: J.C. Penney, Spirit AeroSystems Holdings, The New York Times and Jazz Pharmaceuticals
Date:11/23/2012

CHICAGO, Nov. 23, 2012 /PRNewswire/ -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): J.C. Penney Company, Inc. (NYSE: JCP) and Spirit AeroSystems Holdings, Inc. (NYSE: SPR). Further, Zacks announced #4 Rankings (Sell) on two other widely held stocks: The New York Times Company (NYSE: NYT) and Jazz Pharmaceuticals plc (NASDAQ: JAZZ).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO )

To see the full Zacks #5 Rank List - Stocks to Sell Now visit: http://at.zacks.com/?id=92

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List of Stocks to Sell Now by 80% annually (+2% vs. +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.   

Here is a synopsis of why JCP and SPR have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:

J.C. Penney Company, Inc. (NYSE: JCP) announced third -quarter loss of 93 cents per share on November 12 which came behind the Zacks Consensus Estimate by 85 cents. The diluted earnings per share also fell by 1062.50% on a year-over-year basis. The Zacks Consensus Estimate for the current year slipped $1.40 per share to a loss of 97 cents in the last 30 days. Next year's estimate also dipped $1.0 per share to 65 cents per share in that time span.

Spirit AeroSystems Holdings, Inc. (NYSE: SPR) posted a third -quarter loss of $1.51 per share on November 08, which came in 84 cents wider than the average forecast. The Zacks Consensus Estimate for 2012 fell to a profit of 22 cents per share from $1.89 over the past month with 12 out of 13 covering analysts slashed forecasts. Next year's forecasts slipped 50 cents to $2.11 per share in the same time span.

Here is a synopsis of why NYT and JAZZ have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;

The New York Times Company (NYSE: NYT) third -quarter loss of 1 cent per share, posted on October 25, lagged analysts projections by nearly 112.50%. For 2012, the Zacks Consensus Estimate moved down 12 cent in the last 30 days as 2 out of the 4 covering analysts cut back on forecasts. The forecast for next year slid 12 cents to 54 cents per share in the same time span.

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) reported a third-quarter profit of $1.19 per share on November 8, that fell 0.83% short of the Zacks Consensus Estimate. The full-year average forecast is currently pegged at $4.38 per share, compared with the last 30 days projection of $4.45. Next year's forecast dropped 21 cents per share in the same period.

Truly taking advantage of the Zacks Rank requires the understanding of how it works.  The free special report; "Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions" is available to provide this insightful background. Download a free copy now to prosper in the years to come at http://at.zacks.com/?id=93

About the Zacks Rank

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank Stocks have generated an average annual return of +28%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (2.8% versus +9.7%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=94

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=95

Follow us on Twitter:  http://twitter.com/zacksresearch

Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer:  Past performance does not guarantee future results.  Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Media Contact
Zacks Investment Research 
800-767-3771 ext. 9339  
support@zacks.com  
http://www.zacks.com  

 


'/>"/>
SOURCE Zacks Investment Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
4. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
5. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
6. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
7. InfuSystem Holdings, Inc. Terminates "Poison Pill" Plan
8. Hill-Rom Holdings, Inc. Hosts Fiscal 2012 Third Quarter Earnings Conference Call and Webcast
9. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
10. Ultra Clean Holdings, Inc. Completes Strategic Merger with Advanced Integration Technologies
11. RoundTable Healthcare Partners Announces Sale of Aspen Surgical Products Holding, Inc. to Hill-Rom Holdings, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... "Success Files," a short- ... Alzheimer’s. Alzheimer’s is a disease estimated to affect the lives of more than ... the Alzheimer’s Association, a leading voice in the fight for cure and research ...
(Date:9/22/2017)... Diego, CA (PRWEB) , ... September 22, 2017 ... ... offer groceries, wearable, and more products at customers’ doorstep. According to Smart Mart, ... Smart Mart has stated to offer wearable, and customers can find clothing at ...
(Date:9/21/2017)... ... September 21, 2017 , ... 38-Year-Old Plastic Surgeon Gill at ... Naples, Florida is pleased to announce that Plastic Surgeon Kiranjeet Gill has been awarded ... 40 is an annual award that was started in 2003 to salute young ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing and ... compliance with FDA rules. , The FDA has issued two draft guidances that ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... eat right or exercise more try taking a more holistic approach and use ... Aweganic’s new Amazon essential oil collection is certified USDA guaranteeing that, the new ...
Breaking Medicine News(10 mins):